Metabolic syndrome and insulin resistance comorbidity in systemic lupus erythematosus: Effect on carotid intima-media thickness

Zeitschrift fur Rheumatologie

Volumn 72, Issue 2, 2013, Pages 172-177

  Gheita, T A ^a   Raafat, H A ^a   Sayed, S ^a   El Fishawy, H ^a   Nasrallah, M M ^a   Abdel Rasheed, E ^b  

^a CAIRO UNIVERSITY   (Egypt)

^b NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

HOMA B; HOMA IR; Intima media thickness; Metabolic syndrome; Systemic lupus erythematosus

Indexed keywords

CREATININE; GLUCOSE; INSULIN; LIPID;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CELL FUNCTION; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; QUALITY OF LIFE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; BLOOD GLUCOSE; CAROTID INTIMA-MEDIA THICKNESS; COMORBIDITY; CREATINE; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIPIDS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METABOLIC SYNDROME X; QUALITY OF LIFE;

EID: 84885171529     PISSN: 03401855     EISSN: 14351250     Source Type: Journal    
DOI: 10.1007/s00393-012-1058-9     Document Type: Article

References (36)

1. Mok CC, Wong RW, Lai KN (2003) Treatment of se-vere proliferative lupus nephritis: the current state. Ann Rheum Dis 62:799-804 (Pubitemid 37026486)
2. Cervera R, Khamashta MA, Font J et al (2003) Mor-bidity and mortality in systemic lupus erythemato-sus during a 10-year period: a comparison of ear-ly and late manifestations in a cohort of 1,000 pa-tients. Medicine (Baltimore) 82(5):299-308 (Pubitemid 37229465)
3. Roman MJ, Shanker BA, Davis A et al (2003) Prev-alence and correlates of accelerated atherosclero-sis in systemic lupus erythematosus. N Engl J Med 349(25):2399-2406 (Pubitemid 37542988)
4. Liese AD, Mayer-Davis EJ, Haffner SM (1998) Devel-opment of the multiple metabolic syndrome. An epidemiologic perspective. Epidemiol Rev 20:157-172 (Pubitemid 29045104)
5. Bonora E, Formentini G, Calcaterra F et al (2002) HOMA-estimated insulin resistance is an indepen-dent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Vero-na Diabetes Complications Study. Diabetes Care 25(7):1135-1141 (Pubitemid 41071163)
6. Howard G, O'Leary DH, Zaccaro D et al (1996) Insu-lin sensitivity and atherosclerosis. The Insulin Re-sistance Atherosclerosis Study (IRAS) Investigators. Circulation 93(10):1809-1817
7. Petri M, Spence D, Bone LR, Hochberg MC (1992) Coronary artery disease risk factors in the Johns Hopkins Lupus Cohort: prevalence, recognition by patients, and preventive practices. Medicine Balti-more 71:291-302
8. Petri M, Yoo S-S (1994) Predictors of glucose intol-erance in systemic lupus erythematosus [abstract]. Arthritis Rheum 37(Suppl):323
9. Bruce IN, Urowitz MB, Gladman DD et al (2003) Risk factors for coronary heart disease in women with systemic lupus erythematosus: the Toronto Risk Factor Study. Arthritis Rheum 48:3159-3167 (Pubitemid 37409327)
10. Sada KE, Yamasaki Y, Maruyama M et al (2006) Al-tered levels of adipocytokines in association with insulin resistance in patients with systemic lupus erythematosus. J Rheumatol 33(8):1545-1552 (Pubitemid 44168825)
11. Nourooz-zadeh J, Tajaddini-Sarmadi J, McCarthy S et al (1995) Elevated levels of authentic plasma hy-droperoxides in NIDDM. Diabetes 44:1054-1058
12. Berliner JA, Navab M, Fogelman AM et al (1995) Atherosclerosis: basic mechanism of oxidation, in-flammation and genetics. Circulation 91:2488-2496
13. Lopez LR, Salazar-Paramo M, Palafox-Sanchez C et al (2006) Oxidized low-density lipoprotein and ?2-glycoprotein I in patients with systemic lupus er-ythematosus and increased carotid intima-media thickness: implications in autoimmune-mediated atherosclerosis. Lupus 15:80-86 (Pubitemid 43345332)
14. Kobayashi K, Lopez LR, Shoenfeld Y, Matsuura E (2005) The role of innate and adaptive immuni-ty to oxidized low-density lipoprotein in the de-velopment of atherosclerosis. Ann N Y Acad Sci 1051:442-454 (Pubitemid 41362774)
15. Zampieri S, Iaccarino L, Ghirardello A et al (2005) Systemic lupus erythematosus, atherosclerosis, and autoantibodies. Ann N Y Acad Sci 1051:351-361 (Pubitemid 41362765)
16. Leuven SI van, Kastelein JJ, D'Cruz DP et al (2006) Atherogenesis in rheumatology. Lupus 15(3):117-121
17. Bruce IN (2005) 'Not only..but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus. Rheumatology (Oxford) 44(12):1492-1502 (Pubitemid 41742464)
18. Ryan MJ, McLemore GR, Hendrix ST (2006) Insulin resistance and obesity in a mouse model of systemic lupus erythematosus. Hypertension 48(5):988-993 (Pubitemid 44611014)
19. Bellomio V, Spindler A, Lucero E et al (2009) Metabolic syndrome in Argentinean patients with systemic lupus erythematosus. Lupus 18(11):1019-1025
20. George J, Harats D, Gilburd B et al (1999) Atherosclerosis-related markers in systemic lupus erythematosus patients: the role of humoral immunity in enhanced atherogenesis. Lupus 8(3):220-226 (Pubitemid 29186841)
21. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 40:1725
22. Bombardier C, Gladman DD, Urowitz MB et al (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum 35:630-640
23. Gladman D, Ginzler E, Goldsmith C et al (1996) The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 39:363-369 (Pubitemid 26085211)
24. Spitzer WO, Dobson AJ, Hall J et al (1981) Measuring the quality of life of cancer patients. J Chron Dis 34:585-597
25. Wolfe F, Michaud K, Pincus T (2004) Development and validation of the health assessment questionnaire II: a revised version of the health assessment questionnaire. Arthritis Rheum 50:3296-3305 (Pubitemid 39372007)
26. National Cholesterol Education Program (2001) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults: third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285:2486-2497
27. Manzi S, Selzer F, Sutton-Tyrrell K et al (1999) Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum 42(1):51-60 (Pubitemid 29042570)
28. Vlachoyiannopoulos PG, Kanellopoulos PG, Ioannidis JP et al (2003) Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology 42:645-651 (Pubitemid 37220873)
29. Medina G, Casaos D, Jara LJ et al (2003) Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Dis 62(7):607-610 (Pubitemid 36760555)
30. Esdaile JM, Abrahamowicz M, Grodzicky T et al (2001) Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 44(10):2331-2337 (Pubitemid 32977500)
31. Doria A, Shoenfeld Y, Wu R et al (2003) Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 62(11):1071-1077 (Pubitemid 37323571)
32. Chung CP, Avalos I, Oeser A et al (2007) High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 66(2):208-214 (Pubitemid 46226056)
33. Svenungsson E, Jensen-Urstad K, Heimbürger M et al (2001) Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation 104(16):1887-1893 (Pubitemid 32983229)
34. El Magadmi M, Ahmad Y, Turkie W et al (2006) Hyperinsulinemia, insulin resistance, and circulating oxidized low density lipoprotein in women with systemic lupus erythematosus. J Rheumatol 33(1):50-56 (Pubitemid 43054279)
35. Frostegård J (2002) Autoimmunity: oxidized LDL and cardiovascular disease. Autoimmun Rev 1(4):233-237 (Pubitemid 38340258)
36. McMahona M, Hahna BH (2007) Atherosclerosis and systemic lupus erythematosus: mechanistic basis of the association. Curr Opin Immunol 19(6):633-639